News Features Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile Michael O'Riordan October 17, 2025
News Features As US Abortion Access Grows Patchier, Cardiologist Concerns Mount Todd Neale May 15, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Features As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years Caitlin E. Cox December 16, 2021
News Features Expired Cardiac Devices May Do Global Good, but Safety Unknown Yael L. Maxwell August 26, 2021
News Features Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave Michael O'Riordan January 11, 2021
News Features From Heroes to Humans: How Doctors Found Their Voices in 2020 Caitlin E. Cox December 21, 2020
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Features Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine Shelley Wood December 10, 2020
News Features Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era Todd Neale November 02, 2020
News Features Walloped by COVID-19, US Cardiology Practices Brace for Slow Recovery Todd Neale July 29, 2020
News Features Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope Caitlin E. Cox June 02, 2020
News Features Cardiology After COVID-19: Physicians Predict Lasting Change Yael L. Maxwell May 20, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Features Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms Caitlin E. Cox April 23, 2020
News Features Cardiac Rehab During COVID-19: Telehealth, Unpaid Heroes Step Up to Help at Home L.A. McKeown April 10, 2020
News Features The Mystery of the Missing STEMIs During the COVID-19 Pandemic Shelley Wood April 02, 2020
News Features Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic Yael L. Maxwell March 24, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020